Moreover, we compared TNFRSF1A genomic alterations in three human lung SCC and three human lung ADC cohorts and found that TNFRSF1A amplification was a major type of genomic alteration in the SCC cohorts compared to ADC (Fig. 1d). This evidence concerns the gene TNFRSF1A and medical procedure.